COLAL-PRED Alizyme |
| |
| Authors: | Hanauer Stephen B Sparrow Miles |
| |
| Affiliation: | University of Chicago Medical Center, Department of Medicine, Gastroenterology & Nutrition, MC 9028, 5841 S Maryland Avenue, Chicago, IL 60637, USA. shanauer@medicine.bsd.uchicago.edu |
| |
| Abstract: | COLAL-PRED (prednisolone sodium metasulfobenzoate), which is targeted to the colon by COLAL colonic drug delivery technology, is being developed by Alizyme for the potential treatment of inflammatory bowel disease. Alizyme expect to initiate a phase III trial in 2005. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
